{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/631a89913c2be9001415dc41/67f438fdf20dfdb29b32efbe?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Bad Medicine and Lots of Hope Priced In","description":"<p><strong>Tuesday 8th April 2025</strong></p><p><br></p><p><a href=\"https://www.nab.com.au/content/dam/nabrwd/documents/notice/corporate/nab-research-disclaimer.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">NAB Markets Research Disclaimer</a>&nbsp;</p><p><a href=\"https://www.nab.com.au/financial-services-guide?S_KWCID=SEACT\" rel=\"noopener noreferrer\" target=\"_blank\">Financial Services Guide | Information on our services -</a>&nbsp;<a href=\"https://www.nab.com.au/financial-services-guide?S_KWCID=SEACT\" rel=\"noopener noreferrer\" target=\"_blank\">NAB</a></p><p><br></p><p>Markets were momentarily excited earlier when it seemed that the President might be delaying tariffs for 90 days. Up to that point US equities were continuing to spiral lower, but newfound optimism that Trump might moderate his approach saw a swift reversal. When it emerged that the story was nothing but fake news and, if anything, the President was digging his heals in harder, markets didn’t immediately return to their session lows.&nbsp;NAB’s Tapas Strickland says part of that could be because more CEOs are speaking out against the tariffs and that could force the plans to be rolled back. But, Phil asks, does that mean market have further to go if it becomes clear that&nbsp;the tariffs will stick, and go beyond a temporary negotiating tool.</p>","author_name":"Phil Dobbie"}